Cargando…
Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care
PURPOSE: Over 1 billion doses of COVID-19 vaccines have been already administered across the United States, the United Kingdom and the European Union at the time of writing. Furthermore, 1.82 million booster doses have been administered in the US since 13th August, and similar booster programmes are...
Autores principales: | Garreffa, Emanuele, Hamad, Ahmed, O'Sullivan, Ciara C., Hazim, Antonious Z., York, Joanne, Puri, Shama, Turnbull, Anne, Robertson, John F., Goetz, Matthew P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502686/ https://www.ncbi.nlm.nih.gov/pubmed/34731748 http://dx.doi.org/10.1016/j.ejca.2021.09.033 |
Ejemplares similares
-
Disseminated nocardiosis with infective endocarditis of a transplanted heart
por: Hazim, Antonious Ziad, et al.
Publicado: (2018) -
The emerging role of CDK4/6i in HER2-positive breast cancer
por: O’Sullivan, Ciara C., et al.
Publicado: (2019) -
Mediastinal lymphadenopathy in COVID-19: A review of literature
por: Taweesedt, Pahnwat Tonya, et al.
Publicado: (2021) -
Practical, Methodological, and Ethical Considerations of User Involvement
por: O’Sullivan, Roger
Publicado: (2020) -
Cervical Lymphadenopathy
por: Prasad, Rajeev, et al.
Publicado: (2010)